1 Strategies to Optimize the Antidepressant Action of Selective Serotonin Reuptake Inhibitors --;2 Antidepressant Properties of Specific Serotonin-Noradrenaline Reuptake Inhibitors --;3 5-HT-Moduline: Novel Therapeutic Strategy for Antidepressant Action --;4 Reversible Inhibitors of Monoamine Oxidase A (RIMAs): Where Can We Go from Here? --;5 Calcium Channel Antagonists in Mood Disorders --;6 Functional NMDA Antagonists: A New Class of Antidepressant Agents --;7 Is an Adaptation of NMDA Receptors an Obligatory Step in Antidepressant Action? --;8 NMDA Receptors and Affective Disorders --;9 The Potential Contribution of Sigma Receptors to Antidepressant Actions --;10 A Role for CREB in Antidepressant Action --;11 Antidepressants: Beyond the Synapse --;12 Animal Models to Detect Antidepressants: Are New Strategies Necessary to Detect New Agents? --;13 Molecular Strategies to Novel Antidepressant Discovery.
SUMMARY OR ABSTRACT
Text of Note
In this book, leading-edge investigators offer effective strategies to improve current antidepressive therapies and suggest molecular, biological, and genetic approaches that will lead to the development of novel antidepressants.